Skip to content

Clinical trials

Withdrawn Lung Diseases, Interstitial trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Status: Withdrawn Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20151
20181
20201
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Baylor Research Institute1
Central Hospital, Nancy, France1
Franz Rischard, DO1
Ohio State University1
University of California, Los Angeles1
University of California, San Francisco1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial6
Hypertension, Pulmonary2
Idiopathic Pulmonary Fibrosis1
Lung Diseases1
Lung Neoplasms1
Pulmonary Arterial Hypertension1
Respiratory Aspiration1
Scleroderma, Diffuse1
Scleroderma, Systemic1
Smoke Inhalation Injury1

Trials

Showing 51 to 6 of 6. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.